載入...

COMBINATION THERAPY WITH GLP-1 RECEPTOR AGONIST AND SGLT2 INHIBITOR

The SGLT2 inhibitors (SGLTi) and glucagon-like-1 receptor agonists (GLP-1 RAs) effectively reduce HbA1c, but via very different mechanisms, making them an effective duet for combination therapy. Recently, drugs in both of these antidiabetic classes have been shown to reduce cardiovascular events, mo...

全面介紹

Na minha lista:
書目詳細資料
發表在:Diabetes Obes Metab
主要作者: DeFronzo, Ralph A.
格式: Artigo
語言:Inglês
出版: 2017
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5643008/
https://ncbi.nlm.nih.gov/pubmed/28432726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12982
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!